Latest Licensing News

Page 69 of 154
Everest Metals Corporation has expanded its Revere Gold Project by acquiring the Armstrong tenement, unveiling promising gold mineralisation ahead of its maiden resource estimate.
Maxwell Dee
Maxwell Dee
8 Oct 2025
ECS Botanics reports a positive cash flow milestone in Q1 FY26, driven by strong direct-to-consumer sales and operational efficiencies, while preparing for a European market debut.
Ada Torres
Ada Torres
7 Oct 2025
Australian Wealth Advisors Group Ltd (AWAG) has acquired a 20% stake in First Mutual Australia, marking a key step toward doubling its authorised representatives by mid-2026. This earnings accretive move underpins AWAG’s strategy to build a boutique ‘house of brands’ in financial advisory.
Claire Turing
Claire Turing
7 Oct 2025
Acusensus Limited has landed its first major automated enforcement contract in the US with Connecticut, marking a significant milestone in its American growth strategy. The five-year deal, valued at US$22.6 million, will see the deployment of AI-enabled speed enforcement technology across work zones.
Sophie Babbage
Sophie Babbage
7 Oct 2025
Buxton Resources has significantly expanded its Centurion Project in Western Australia, securing a new exploration license and preparing for geophysical surveys following encouraging drillhole assays.
Maxwell Dee
Maxwell Dee
7 Oct 2025
Echo IQ’s application for a Category III CPT code was declined by the AMA, but the company is exploring reconsideration and new AI-specific coding frameworks to advance US reimbursement.
Ada Torres
Ada Torres
6 Oct 2025
Aurum Resources has announced a significant 53% increase in Indicated Resources at its Boundiali Gold Project in Côte d'Ivoire, lifting the total Indicated ounces to 0.92 million and maintaining total resources at 2.41 million ounces. This milestone underscores the company's rapid drilling capabilities and sets the stage for a Pre-Feasibility Study expected in early 2026.
Maxwell Dee
Maxwell Dee
6 Oct 2025
The U.S. FDA has lifted the clinical hold on Neurizon Therapeutics’ lead drug candidate NUZ-001, enabling its entry into a major ALS platform trial set for Q4 2025. This regulatory milestone accelerates the company’s clinical development and opens doors for broader neurodegenerative applications.
Ada Torres
Ada Torres
6 Oct 2025
DigitalX Limited has responded to ASX queries, affirming the legality of its cryptocurrency treasury strategy and outlining plans to expand Bitcoin holdings significantly by 2027 to support its digital asset business.
Claire Turing
Claire Turing
3 Oct 2025
Meteoric Resources has obtained crucial environmental consent to operate within the sensitive buffer zone of the Serra da Pedra Branca sanctuary, clearing a major hurdle for its Caldeira Rare Earth Project in Brazil.
Maxwell Dee
Maxwell Dee
3 Oct 2025
Aurora Labs has secured a $450,000 Phase 2 contract from the Australian Department of Defence to prototype a high-thrust, fuel-efficient propulsion system for unmanned aerial systems, building on its innovative 3D metal printing technology.
Victor Sage
Victor Sage
3 Oct 2025
Altamin Limited has extended the closing date for its retail entitlement offer to 15 October 2025, aiming to raise up to AUD 6.46 million to support its mining projects.
Maxwell Dee
Maxwell Dee
3 Oct 2025